Breaking Barriers Inside and Outside of Clinical Trials

Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses the key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.